Jan/Feb 2021 • PharmaTimes Magazine • 4-5


Contents


Features

Dr Paul Cornes on the promise of biosimilars


Dr Andrew Rut considers pharma's role in
COVID-19 vaccination adherence


John Pinching talks evolution and revolution within medical communications


Will the events of 2020 drive a transformation in clinical research? EB McLindon takes a look


Professor Trevor Jones offers an in-depth look at medical cannabis


Analysis

Ana Nicholl's outlook on what this year might have in store for the sector


Oli Hudson looks at what the data tells us
so far


Paul McGrade's take on what the pharma
industry should focus on now


Dave Williams' predictions for COVID-19's continued influence on the industry


SmartPeople

Patient involvement in medical
communications, by Michael Pellegrino,
SVP, Head of Scientific Services, Global
Medical Communications, ICON


Emily McKechnie's experiences with XLH